Intas B2B Dossier e-portfolio
Intas B2B Dossier e-portfolio is made and published by Intas Pharmaceuticals Ltd. AppBrain is an independent app data site and isn't affiliated with Intas Pharmaceuticals Ltd. The app name, icon, screenshots and description belong to Intas Pharmaceuticals Ltd and are shown as published on the App Store.
AppBrain's verdict
- Last updated
- August 27, 2026
Rankings
App Store top chartsApp Store Rankings for Intas B2B Dossier e-portfolio
Competitors
Similar apps and more from Intas Pharmaceuticals LtdAlternatives to Intas B2B Dossier e-portfolio
More from Intas Pharmaceuticals Ltd
Releases
Updates seen on the App Store- Version
- 5.0.9
- Launched
- February 2016
No changelog data
User feedback
Ratings and reviews on the App StoreComments on Intas B2B Dossier e-portfolio for iOS
We don't have enough comments to show example comments. Please check back later.
Technology
Found in the app by AppBrain- Price
- Free
- App size
- 19.8 MB
- Content rating
- Everyone
Technologies used by Intas B2B Dossier e-portfolio
About the app and developer
About Intas B2B Dossier e-portfolio
Intas B2B Dossier e-portfolio is a medical app developed by Intas Pharmaceuticals Ltd.
User Ratings
The app has no ratings yet.
App Information
Intas B2B Dossier e-portfolio is freely available from the App Store. The app size is 19.80 MB. The latest version available is 5.0.9. The last update was on August 27, 2026.
Technical Requirements
The app has a content rating of Everyone. The app has been available on the App Store since February 2016.
Developer information for Intas Pharmaceuticals Ltd
Address:
Frequently asked questions about Intas B2B Dossier e-portfolio
Is Intas B2B Dossier e-portfolio free?
Yes. Intas B2B Dossier e-portfolio is free on the App Store.
Is Intas B2B Dossier e-portfolio still available?
Yes. Intas B2B Dossier e-portfolio is on the App Store, and the last update we saw was on August 27, 2026.
How large is Intas B2B Dossier e-portfolio?
Intas B2B Dossier e-portfolio is 19.80 MB.
Is Intas B2B Dossier e-portfolio suitable for children?
App Store rates the content of Intas B2B Dossier e-portfolio as suitable for everyone.
Who made Intas B2B Dossier e-portfolio?
Intas B2B Dossier e-portfolio was developed by Intas Pharmaceuticals Ltd. It is listed in the medical category on the App Store.
What are the best alternatives to Intas B2B Dossier e-portfolio?
People looking at Intas B2B Dossier e-portfolio also look at these medical apps: Comfort Smart⁺, IIEF-5 Erectile Dysfunction, Rx Billing Genie RXBG, VEITHsymposium 2022, Freedom From Diabetes App.
Store listing
By Intas Pharmaceuticals Ltd, from the App Store
Description by Intas Pharmaceuticals Ltd Written by the developer, not by AppBrain. Click to read.
Access to visual overviews on regulatory information and launch landscape.
Search through our portfolio using filters as stability clime zone, jurisdiction, therapeutic area and more.
Always updated with our last developments, filing plan and available MAs.